Results 1 to 10 of about 4,432 (222)

Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells. [PDF]

open access: yesPLoS Biology, 2023
The viral hemagglutinins of conventional influenza A viruses (IAVs) bind to sialylated glycans on host cell surfaces for attachment and subsequent infection. In contrast, hemagglutinins of bat-derived IAVs target major histocompatibility complex class II
Okikiola M Olajide   +10 more
doaj   +5 more sources

A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. [PDF]

open access: yesPLoS ONE, 2012
Recently, a new class of broadly neutralizing anti-influenza virus antibodies that target the stalk domain of the viral hemagglutinin was discovered. As such, induction, isolation, characterization, and quantification of these novel antibodies has become
Florian Krammer   +5 more
doaj   +2 more sources

Structural and Functional Aspects of G-Quadruplex Aptamers Which Bind a Broad Range of Influenza A Viruses [PDF]

open access: yesBiomolecules, 2020
An aptamer is a synthetic oligonucleotide with a unique spatial structure that provides specific binding to a target. To date, several aptamers to hemagglutinin of the influenza A virus have been described, which vary in affinity and strain specificity ...
Anastasia A. Novoseltseva   +9 more
doaj   +2 more sources

Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines [PDF]

open access: yesJournal of Virology
The 2023/2024 influenza vaccine included an updated H1N1 component designed to better match a new clade of H1N1 that had multiple mutations in antigenic epitopes of hemagglutinin.
Andrea N. Loes   +15 more
doaj   +2 more sources

cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice

open access: yesMolecular Therapy: Nucleic Acids, 2022
Increasing preclinical and clinical results have demonstrated that mRNA vaccines efficiently prevent infectious diseases and are safe in animal models and humans.
Wandi Zhu   +7 more
doaj   +1 more source

SOME INVESTIGATIONS ON RABBIT VIRAL HAEMORRHAGIC DISEASE IN UPPER EGYPT [PDF]

open access: yesAssiut Veterinary Medical Journal, 1994
Rabbit hamorrhagic disease (RHD) outbreaks were observed during winter and spring, 1993 in most rabbitaries of Upper Egypt (Minia, Assiut and Sohage Provinces) with mortality rate of 26.7 up to 100% in4-16 month-old rabbits.
K.EL ZANATY
doaj   +1 more source

The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype. [PDF]

open access: yesPLoS ONE, 2013
Different diseases require different immune responses for efficient protection. Thus, prophylactic vaccines should prime the immune system for the particular type of response needed for protection against a given infectious agent.
Gunnveig Grødeland   +4 more
doaj   +1 more source

An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets

open access: yesnpj Vaccines, 2022
There is a crucial need for an improved H3N2 influenza virus vaccine due to low vaccine efficacy rates and increased morbidity and mortality associated with H3N2-dominated influenza seasons.
Brianna L. Bullard   +6 more
doaj   +1 more source

Heterosubtypic immunity increases infectious dose required to infect Mallard ducks with Influenza A virus. [PDF]

open access: yesPLoS ONE, 2018
Previous field and experimental studies have demonstrated that heterosubtypic immunity (HSI) is a potential driver of Influenza A virus (IAV) prevalence and subtype diversity in mallards.
Karen M Segovia   +6 more
doaj   +1 more source

Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection

open access: yesVaccines, 2021
Vaccination is the best way to prevent influenza virus infections, but the diversity of antigenically distinct isolates is a persistent challenge for vaccine development.
Ying Huang   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy